📅 PUBMED DAILY TRIAGE — 2026-03-23

Window: 2026-03-22T00:00Z → 2026-03-23T23:59Z (CRDT) Topics scanned: 10 | Articles reviewed: 12 High priority: 0 | Standard: 6 | Low/archive: 6 | Unsolicited finds: 1 Run status: SUCCESS

🔴🟠 HIGH PRIORITY

No articles met the HIGH priority threshold (triage_score ≥ 8 or EARLY_CANCER_DETECTION / NOVEL_TREATMENT flag with sufficient evidence) today.

🟢⚪ STANDARD

PMID-41869271 · Risks of Myocardial Infarction and Mortality in Patients with Incident Rheumatoid Arthritis Compared with a Matched General Population: A Danish Nationwide Cohort Study · 7/10 · Large (n=125,622) Danish nationwide cohort shows 41% decline in 5-year MI risk and 17% mortality decline in RA patients 1996–2017, but RA still carries ~50% excess MI risk vs general population — statin prescription at only 19% suggests major prevention gap. (Public Health / Validated)

PMID-41869033 · The impact of maternal gestational diabetes mellitus on cardiac structural and functional parameters in infants · 7/10 · Retrospective cohort (n=11,782) finds GDM exposure associated with larger infant cardiac chamber dimensions, sex-specifically in males under 6 months — potential early cardiovascular risk signal in GDM offspring. (Prevention / Validated)

PMID-41869312 · Advances in donor-derived cell-free DNA monitoring for solid organ transplantation · 6/10 · Comprehensive review of dd-cfDNA assay technologies (NGS vs digital PCR) for post-transplant graft surveillance; highlights lack of threshold standardization as a key implementation barrier. (Diagnostics / Validated)

PMID-41869413 · Lipid-Engineered Small-Sized Metal-Organic Frameworks for Targeted Delivery of Anlotinib in Lung Cancer Treatment · 4/10 · Preclinical study demonstrates AML nanocarrier (MOF + liposome) outperforms free anlotinib in murine lung cancer models via dual pH-responsive release + Fenton-like ROS; no systemic toxicity observed. (Drug Development / Exploratory — preclinical only)

PMID-41869410 · Targeted Delivery of Nucleic Acid Therapeutics: Emerging Carriers and Applications in Common Metabolic and Inflammatory Diseases · 4/10 · 2020-2025 review of LNP, polymer, EV, and conjugate delivery platforms for mRNA/siRNA/ASO/circRNA in metabolic and inflammatory disease contexts. (Drug Development / Exploratory — review)

PMID-41869409 · Recent Advances in Nanoscale Sprayable Hydrogels for Cancer Management · 3/10 · Preclinical review of sprayable hydrogel platforms integrating checkpoint inhibitors and chemotherapy with up to 95% residual tumor reduction in models; clinical translation blocked by sterilization and regulatory hurdles. (Drug Development / Exploratory — review only)

💡 UNSOLICITED FINDS

PMID-41869177 (tentative) · Novel therapeutic approach in rare disease with high unmet need · Score: 3/10 (abstract pending) · Identified from rare disease + sentinel overlap; full abstract not retrieved — flagged as potential unsolicited find for verification next run.

📊 TODAY'S BREAKDOWN

By research category:

• Public Health: 2
• Drug Development: 3
• Diagnostics: 2
• Prevention: 1
• Other/Editorial: 1
• Pending (abstract missing): 3

By evidence maturity:

• Validated: 3
• Exploratory: 7
• Pending: 2

By watchlist topic (articles matched):

• Cardiovascular-metabolic (GLP-1/SGLT2/cardiometabolic): 3
• Novel therapeutics (immunotherapy/CAR-T/targeted): 3
• AI/ML in clinical diagnostics: 2
• Early cancer detection (cfDNA/ctDNA): 1
• Hematologic malignancies: 1 (editorial, excluded)
• Precision oncology: 1 (pending)
• Aging/longevity/population health: 1 (pending)
• Rare diseases: 1 (pending, unsolicited)

By source type:

• Peer-reviewed: 12 | Preprint: 0

🔧 RUN NOTES

• First run: No prior state.json found; used default 24-hour CRDT window (2026-03-22 to 2026-03-23).
• Rate limit: NCBI 429 encountered once; resolved with 3-second back-off.
• XML truncation: 5 records (PMIDs 41869384, 41869362, 41869396, 41869013, 41869177) had abstracts unavailable due to 50KB fetch truncation in bulk XML responses. These records are scored conservatively (≤3) and flagged for retry in the next run. They are NOT silently dropped — they appear in the JSON batch as low-confidence placeholders.
• Sentinel scan: Raw count 752 (broad query); reviewed top results; 1 unique item carried forward as unsolicited find candidate.
• AI/ML diagnostics: 111 raw results; top 20 reviewed; 3 records deduped across topics; 2 still pending abstract fetch.
• No HIGH priority alerts triggered today — zero articles reached triage_score ≥ 8 or met EARLY_CANCER_DETECTION / NOVEL_TREATMENT flag with sufficient evidence maturity. No Telegram alert sent.
• Editorial excluded: PMID-41869334 (EBV/lymphoma editorial) excluded from pipeline per schema.
• State.json created: Checkpoint and fingerprints saved for next incremental run.